NeuroSense Therapeutics Ltd. (NRSN) stock
NRSNNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NRSNW
$1.37−0.14 (-9.27%)
Close on Nov 18, 2026Market cap $2.52MP/E –Yield –
NeuroSense Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
NeuroSense Therapeutics's price to book ratio was 16.2× on Jul 31, 2025, against 2.6× a year earlier. Over the last 2 years it ranged from 0.0× to 17.0×, with a median of 2.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jul 31, 2025 | 16.2× | +16.1 |
| 2024 | Jan 31, 2024 | 0.1× | +0.0 |
| 2023 | Dec 29, 2023 | 0.1× | −0.3 |
| 2022 | Jul 29, 2022 | 0.3× | – |
See a number that looks wrong?